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Abstract
Varicella-zoster virus (VZV) causes a diverse spectrum of neurologic complica-
tions: aseptic meningitis, encephalitis, cerebral infarction associated with granu-
lomatous vasculitis, myelitis, and cranial polyneuropathy. These VZV-associated 
central nervous system (CNS) diseases usually result from reactivation of latent 
infection in immunosuppressive conditions, such as old age, diabetes mellitus, 
cancer, human immunodeficiency virus (HIV) infection, and the use of immuno-
suppressive drugs. However, they also occur in immunocompetent subjects. Since 
VZV antigen or DNA is often detected in the cerebrospinal fluid of these patients, it 
is thought that reactivated VZV reaches the central nervous system by direct spread 
from latently infected sensory ganglia. Analysis of cerebrospinal fluid by PCR is 
important for the diagnosis of VZV-associated CNS diseases particularly in the 
absence of exanthema/herpes zoster. Clinicians should be aware of the neurologic 
complications of VZV infection, because early acyclovir therapy is necessary for 
these disorders.
Keywords: varicella-zoster virus (VZV), neurologic infections,  
central nervous system (CNS), encephalitis, meningitis
1. Introduction
The clinical manifestations of varicella-zoster virus (VZV) infections of the 
central nervous system (CNS) include aseptic meningitis, encephalitis, cerebral 
infarction associated with granulomatous vasculitis, myelitis, and multiple cranial 
neuropathies (Figure 1) [1–4]. In these patients, viral antigens or DNA are often 
detected in the cerebrospinal fluid (CSF) or the sites of pathology. Thus, those 
neurological disorders reflect reactivation of latent VZV in the trigeminal ganglia 
and dorsal root ganglion, with subsequent spread of the infection into the CNS 
[1]. In addition, the incidence of CNS complications caused by VZV is more likely 
higher in elderly individuals; those with underlying diseases, such as malignant 
tumors and HIV; and those who are immunosuppressed due to the use of steroids 
or immunosuppressive drugs [5–8]. However, it can also affect healthy individuals; 
therefore, these CNS VZV infections may be suspected even in patients without 
underlying diseases. Among CNS infections caused by VZV, diseases other than 
meningitis are rare; however, clinicians should be aware of the various clinical 
features of CNS infections caused by VZV to start early and accurate antivirus drugs 
for treatment.
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2. Zoster sine herpete
If neurological symptoms occur simultaneously or around the same time as 
the onset of herpes zoster infection, they can be considered complications of VZV 
infections. However, if lesions such as rashes, shingles, or blisters are not observed, 
VZV as a causative agent is likely to be missed. In fact, because VZV can cause CNS 
complications in the absence of skin lesions, such cases are referred to as zoster sine 
herpete [9]; clinicians have to consider the possibility of VZV as a causative virus in 
patients with neurological infections, such as meningitis or encephalitis (Figure 1).
3. Aseptic meningitis
Meningitis is inflammation of the pia mater and the arachnoid that cover the sur-
face of the brain. Its clinical signs include fever, headache, nausea, vomiting, and men-
ingeal irritation symptoms, such as nuchal rigidity and Kernig’s sign. Furthermore, 
jolt accentuation and neck flexion tests are often positive. However, these are common 
symptoms and findings of meningitis regardless of the cause. The CSF examination 
shows monocyte-dominant pleocytosis and elevated protein levels with normal 
glucose levels. Patients with meningitis wherein bacteria are not detected via the CSF 
test are generally diagnosed as having aseptic meningitis. Most cases of aseptic men-
ingitis involve viral meningitis. The most common virus that causes viral meningitis is 
enterovirus. In adults, enterovirus is followed by herpes simplex virus type 2 (HSV-2) 
and VZV [10], and VZV infection accounts for 8% of the total meningitis cases [11].
VZV meningitis can sometimes cause cranial polyneuropathy or dysuria due to 
sacral radiculopathy, and dysuria due to sacral radiculopathy is known as Elsberg 
syndrome. Meningitis caused by VZV is also frequently observed among healthy 
young individuals. Such a condition generally has a good prognosis and rarely 
causes any sequelae.
4. Elsberg syndrome
Elsberg syndrome is caused by bilateral sacral radiculopathy, which is charac-
terized by urinary retention, sensory disturbance, and neuralgia of the perineum 
Figure 1. 
Neurological complications associated with VZV reactivation.
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and lower limbs. Although Elsberg syndrome was originally characterized by 
urinary retention due to sacral radiculopathy associated with genital herpes, it is 
now defined as aseptic meningitis-associated sacral radiculopathy. As the causative 
virus, HSV, particularly HSV-2, is the most common cause, followed by VZV  
[12, 13]. When urinary retention occurs, urethral catheterization is required. 
However, this condition resolves as meningitis improves.
4.1 Case 1: Elsberg syndrome
A 32-year-old man was admitted to our hospital because of high fever, headache, 
nausea, acute urinary retention, and dysesthesia in a lumbosacral dermatome dis-
tribution. There were no motor symptoms and no rash. CSF analysis showed 249 
leukocytes/mm3, 70 mg/dl protein, and positive of VZV DNA by PCR. Gadolinium-
enhanced MRI revealed the meningeal lesions of the conus medullaris and the swollen 
radicular fibers in the upper lumbar spinal canal. Treatment of acyclovir and dexa-
methasone for 2 weeks led to complete resolution of meningitis and urinary retention.
5. Encephalitis and cerebral infarction associated with granulomatous 
vasculitis
The symptoms of encephalitis include acute disturbance of consciousness, 
headache, fever, and convulsions. Neurological findings of encephalitis include 
meningeal irritation symptoms, such as nuchal rigidity; however, patients with 
encephalitis sometimes present with motor paralysis and sensory disturbance due to 
parenchymal brain damage.
Among the pathogens that cause viral encephalitis, VZV is the second most com-
mon cause following HSV, accounting for 5% of the total encephalitis cases [14]. 
According to a recent analysis that used PCR, though, the risk of VZV encephalitis 
increases in elderly individuals, those with herpes zoster ophthalmicus, and those 
with disseminated herpes zoster, and this result indicates that the incidence of VZV 
encephalitis might have increased [15].
The clinical manifestations of VZV encephalitis include meningoencephalitis 
and vasculopathy [16]. The meningoencephalitis form shows no detectable lesions 
on MRI. In contrast, the vasculopathy form is characterized by non-specific 
ischemia, hemorrhagic lesions, and multiple white matter lesions on MRI [16]. 
Pathological studies suggested that VZV encephalitis develops based on vasculopa-
thy in the large and small vessels. Therefore, MRI typically demonstrates ischemic 
or hemorrhagic infarction in both gray and white matter and particularly at gray-
white matter junctions as characteristic imaging findings of VZV encephalitis [16]. 
In VZV encephalitis, lesions in the temporal lobe and limbic system, which are often 
observed in patients with herpes simplex encephalitis, are rare. Moreover, hemor-
rhagic lesions and necrosis, which are characteristics of herpes simplex encephalitis, 
are not commonly observed. Because VZV DNA is generally detected in the CSF of 
adult patients with VZV encephalitis, direct viral invasion to the CNS is believed 
to be the pathology of VZV encephalitis. In contrast, in varicella encephalitis in chil-
dren who develop acute cerebellar ataxia associated with varicella infection, VZV is 
not detected in the CSF. Therefore, a secondary immunological allergic mechanism 
is considered as the pathology of varicella encephalitis.
Cerebral infarction caused by granulomatous vasculitis is a complication of 
herpes zoster infection [1, 17]. A typical patient presents with herpes zoster oph-
thalmicus, followed by postherpetic contralateral hemiplegia, and develops cerebral 
infarction between the eighth day and sixth month after herpes zoster infection 
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(average of 7 weeks) [18, 19]. Patients with cerebral infarction often present with 
stenosis or obstruction in the anterior cerebral artery or middle cerebral artery. 
Because VZV DNA and antigens are detected in the walls of cerebral arteries, this 
evidence should provide an anatomic pathway for transaxonal spread of VZV 
after reactivation from trigeminal ganglia as a mechanism of intracerebral VZV 
vasculopathy [20–22]. The incidence of stroke increases 6 months after the onset of 
herpes zoster infection [23], and VZV vaccine and antiviral drug therapy may help 
reduce the risk of stroke after herpes zoster infection [24]. Cerebral infarction can 
also develop after varicella infection in children [25]. Although it is rare, it occurs 
within 6 months after varicella infection, and a similar mechanism as cerebral 
infarction after varicella zoster infection is considered [25]. In these conditions, 
VZV, which causes latent infection in the trigeminal ganglion after varicella infec-
tion, reactivates and directly invades the vessels in the CNS.
5.1 Case 2: meningoencephalitis
The patient was a 77-year-old woman who was admitted to our hospital due 
to convulsions and impaired consciousness. She presented with a Glasgow Coma 
Scale score of E1V1M4, and positive nuchal rigidity was observed. The convulsions 
were treated with the intravenous injection (IV) of diazepam and intramuscular 
injection of phenobarbital. However, the patient had high fever after admission at 
the hospital. CSF examination showed increased cell count (125.0 mg/dl), elevated 
protein level (125.0 mg/dl), and positivity for VZV DNA, and she was then diag-
nosed with VZV infection. The patient was treated with acyclovir and dexametha-
sone, and she regained consciousness and was able to talk on the second day of 
hospitalization. On the seventh day, she recovered with lucid consciousness without 
sequelae (Figure 2). Her MRI showed no abnormal lesions in the brain parenchyma, 
and she was diagnosed with meningoencephalitis.
5.2 Case 3: cerebral infarction associated with granulomatous vasculitis
The patient was a 76-year-old man who developed infarction in the right medial 
hypothalamus 34 days after the onset of right ophthalmic herpes zoster. He further 
Figure 2. 
Clinical course (Case 1).
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developed an infarction in the right occipital lobe 73 days after the onset of herpes 
zoster infection. Although the MRI obtained while the patient presented with 
herpes zoster rash did not show any abnormal findings, the MRI performed 73 days 
later showed severe stenosis of the posterior communicating artery.
5.3 Case 4: cerebral infarction associated with granulomatous vasculitis
The patient was a 52-year-old woman with systemic lupus erythematosus (SLE) 
who exhibited altered levels of consciousness during immunotherapy for SLE. The 
CSF test showed pleocytosis, an elevated protein level, and positivity for VZV DNA, 
and the patient was then diagnosed with VZV meningoencephalitis. Brain MRI 
showed cerebral infarction in the left cerebral white matter, and MR angiogram 
showed stenosis of the left middle cerebral artery.
6. Cranial polyneuropathy
Cranial nerve palsy can sometimes develop in patients with herpes zoster of 
face or neck regions. Facial nerve palsy accompanying herpes zoster infection is 
known as Ramsay Hunt syndrome, and those patients often exhibit cranial poly-
neuropathy [26, 27]. Lower cranial polyneuropathy causes dysphagia, dysarthria, 
and hoarseness. Furthermore, there was no elevation or constriction in the unilat-
eral soft palate, and tongue deviation and muscular weakness of the sternocleido-
mastoid and trapezius muscles were observed due to unilateral glossopharyngeal, 
vagus, accessary, and hypoglossal nerve paralyzes. Cranial polyneuropathy is 
often accompanied by meningitis, and CSF examination showed pleocytosis and 
elevated protein levels. In most cases, brain MRI shows no abnormalities. However, 
contrast MRI sometimes shows enhancement in the affected cranial nerves. As a 
mechanism of this condition, reactivation of VZV from the geniculate ganglion 
could result inflammatory process, circulatory disturbance, or edema to involve 
cranial nerves [28].
6.1 Case 5: lower cranial polyneuropathy
A 64-year-old woman developed acute paralysis of the IX, X, XI, and XII nerves 
on the left side after experiencing pain in the left ear and throat. CSF examina-
tion revealed lymphocytic pleocytosis and elevated protein levels. VZV DNA was 
detected with PCR using CSF. She was diagnosed with cranial polyneuropathy due 
to VZV reactivation. After the oral administration of antiviral agent and steroid, 
all signs and symptoms dramatically improved. Notably, there was no evidence of 
cutaneous or mucosal rash during the entire course of the disease. VZV reactivation 
should be included in the differential diagnosis of multiple cranial nerve palsies, 
particularly with pain and even without rash.
6.2 Case 6: lower cranial polyneuropathy
The patient was a 66-year-old man who presented with dysphagia and hoarse-
ness 2 days after the onset of pain in the left occipital region to the shoulder. At an 
otorhinolaryngology clinic, recurrent nerve paralysis was observed, and lesions of 
herpes zoster were noted in the left side of the neck. Left glossopharyngeal, vagal, 
accessory, and hypoglossal nerve paralyzes were observed during neurological 
examination. CSF examination showed increased cell count and positivity for VZV 
DNA, and the patient was diagnosed with multiple lower cranial polyneuropathy.
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7. Myelitis
VZV myelitis is a rare clinical manifestation. However, Brown-Séquard syn-
drome and transverse myelopathy may occur as a complication of herpes zoster 
infection [6, 7, 29–31]. Previous reports revealed that myelitis occurred in elderly 
or immunocompromised patients, such as those with HIV infection, and this 
condition often had severe sequelae such as motor paralysis [6, 7]. MRI shows 
low to equal signal intensity on T1-weighted images and high signal intensity on 
T2-weighted images, and sometimes, contrast enhancement can be observed as 
spinal cord lesions. In addition, MRI enhancement may be observed not only in the 
lesions in the spinal cord but also in the meninges around the spinal cord as well as 
in the dorsal root nerve, and these findings indicate myeloradiculitis.
Myelitis is often characterized by myelopathy at a level consistent with the spinal 
segment affected by herpes zoster. As a pathogenesis of this condition, reactivated 
VZV in the dorsal root ganglion of the spinal cord directly invades the spinal cord 
from the dorsal root nerve, resulting in myelitis [6, 7]. Moreover, spinal cord lesions 
are caused by vasculopathy, such as damage to the anterior spinal artery due to 
vasculitis, similar to cerebral infarction after herpes zoster infection, and this may 
be considered another mechanism.
7.1 Case 7: myelitis
The patient was a 60-year-old man with right lower extremity paralysis and 
sensory disturbance of the right trunk and lower extremity who was diagnosed with 
VZV myelitis based on CSF examination. MRI of the spinal cord showed a high-
signal lesion in the right posterior funiculus at the thoracic vertebral level of Th6 
and Th7, which should indicate that VZV directly invaded the spinal cord from the 
dorsal root.
7.2 Case 8: myelitis
An 87-year-old woman developed weakness of the right lower limb 2 days after 
developing herpes zoster lesions in the right side of the chest. Neurological examina-
tion revealed a spastic palsy in the right lower limb and loss of pain and temperature 
sensation in the left side to T6. However, vibration and position senses were not 
impaired in both sides. Thus, the patient presented with incomplete Brown-Séquard 
syndrome. Spinal T2-weighted MRI images showed a high-intensity lesion in the right 
side of the spinal cord except at the posterior funiculus at the Th2 level. CSF analysis 
showed the following results: leukocyte count, 109/mm3, and protein level, 79 mg/dl,  
as well as negativity for VZV PCR, elevated titer levels for anti-VZV IgM and IgG, 
and increased IgG index. Although she was treated with a combination of acyclovir 
and steroid pulse therapy, her weakness in the right lower limb did not improve. In 
this case, because the posterior funiculus circulating from the posterior spinal artery 
was not involved, the incomplete Brown-Séquard syndrome may have been caused by 
spinal cord infarction due to VZV vasculitis of the anterior spinal artery.
8. Postherpetic neuralgia
Although most cases of acute herpes zoster are self-limited, about 10–15% of 
patients with herpes zoster will develop postherpetic neuralgia (PHN) [32], par-
ticularly in older adults [33]. Immunosuppressed patients have a higher incidence 
of PHN. PHN refers to pain persisting for months to years after the resolution of the 
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rash. Sensory symptoms can include pain, numbness, dysesthesias, and allodynia 
(pain precipitated by movement) in the affected dermatome. And these symptoms 
may be severe enough to restrict sleep, appetite, or daily activities. The diagnosis 
of PHN is clear-cut and could be made if those sensory symptoms including pain 
persist beyond 4 months in the same distribution as a preceding episode of acute 
herpes zoster [34]. Gabapentin, pregabalin, tricyclic antidepressants, and opioids 
are generally the first-line drugs for the treatment of PHN [35–37]. Vaccines are also 
available for prevention of acute zoster and PHN [38, 39].
9. Diagnosis
For the diagnosis of CNS infection caused by VZV, the detection of VZV DNA 
with PCR using CSF is necessary [40–42]. However, a negative VZV DNA result 
does not rule out VZV infection, and particularly, PCR examination after the 
initiation of antiviral treatment will likely turn out negative. Thus, testing should 
be conducted using CSF before the antiviral treatment. When measuring anti-VZV 
antibodies, a significant increase of the anti-VZV antibody titer in CSF over the 
course of the illness or findings suggesting the production of intrathecal antibody 
[serum/CSF antibody ratio ≤ 20 or antibody titer index = (CSF antibody/serum 
antibody)/(CSF albumin/serum albumin ≥ 2)] should be confirmed.
10. Therapy
Antiviral therapy with intravenous acyclovir (10 mg/kg intravenous every 
8 hours) should be initiated as soon as the diagnosis is considered [43]. Although 
the prognosis of meningitis is good, encephalitis and myelitis often result in 
sequelae, and a delay in the initiation of acyclovir treatment leads to poor prognosis. 
Therefore, if CNS infection caused by VZV is suspected based on clinical symptoms 
as well as CSF examination and imaging findings, the administration of acyclovir 
must be immediately initiated. According to a recent study from the UK, some 
causative pathogens were identified in 42% of acute encephalitis cases, of which 
HSV or VZV was identified in one-fourth of the cases. Thus, the administration of 
acyclovir should be immediately initiated if encephalitis is clinically suspected, and 
then, acyclovir should be administered for 2 weeks in an immunocompetent host 
and for 3 weeks in an immunosuppressive host if encephalitis caused by HSV or 
VZV is confirmed [5]. In CNS infection caused by VZV, the standard administration 
period is similar. There is no evidence showing the therapeutic effect of adjunctive 
corticosteroid use. However, corticosteroids suppress the inflammatory response 
accompanied by cytotoxicity due to the host immune response to viral infection, 
and in cases of encephalitis/vasculitis, myelitis, and cranial polyneuropathy, the 
adjunctive administration of dexamethasone or steroid pulse therapy with acyclovir 
is recommended.
11. Conclusions
VZV causes the diverse spectrum of neurologic complications: aseptic menin-
gitis, encephalitis, cerebral infarction associated with granulomatous vasculitis, 
myelitis, and cranial polyneuropathy. Clinicians should be aware of the neurologic 
complications of VZV, because early acyclovir therapy is necessary for these 
disorders.
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